| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8759 |
| Human Intestinal Absorption | HIA+ | 0.6909 |
| Caco-2 Permeability | Caco2- | 0.6591 |
| P-glycoprotein Substrate | Non-substrate | 0.8334 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9923 |
| Non-inhibitor | 0.9900 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9596 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7983 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8520 |
| CYP450 2D6 Substrate | Non-substrate | 0.8959 |
| CYP450 3A4 Substrate | Non-substrate | 0.7965 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9092 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9076 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9462 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9377 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9607 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9871 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9678 |
| Non-inhibitor | 0.9839 |
| AMES Toxicity | Non AMES toxic | 0.9365 |
| Carcinogens | Non-carcinogens | 0.5722 |
| Fish Toxicity | High FHMT | 0.6520 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9588 |
| Honey Bee Toxicity | High HBT | 0.7502 |
| Biodegradation | Ready biodegradable | 0.9382 |
| Acute Oral Toxicity | III | 0.5544 |
| Carcinogenicity (Three-class) | Non-required | 0.7104 |